mGlu3 Antagonists:アンタゴニストのグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014453)
◆英語タイトル:mGlu3 Antagonists -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014453
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[mGlu3 Antagonists:アンタゴニストのグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“mGlu3 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under mGlu3 Antagonists. This report provides information on the therapeutic development based on the mGlu3 Antagonists dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of mGlu3 Antagonists
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the mGlu3 Antagonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for mGlu3 Antagonists and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for mGlu3 Antagonists
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding mGlu3 Antagonists pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• mGlu3 Antagonists Overview
• mGlu3 Antagonists Disease Associated
• mGlu3 Antagonists Pipeline Therapeutics
• mGlu3 Antagonists Therapeutics under Development by Companies
• mGlu3 Antagonists Late Stage Products (Filed and Phase III)
• Comparative Analysis
• mGlu3 Antagonists Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• mGlu3 Antagonists Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• mGlu3 Antagonists Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• mGlu3 Antagonists – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• mGlu3 Antagonists – Discontinued Products
• mGlu3 Antagonists – Dormant Products
• Companies Involved in Therapeutics Development for mGlu3 Antagonists
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for mGlu3 Antagonists by Therapy Area, 2014
• Number of Products under Development for mGlu3 Antagonists, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• mGlu3 Antagonists Assessment by Monotherapy Products
• mGlu3 Antagonists Assessment by Combination Products
• mGlu3 Antagonists Assessment by Route of Administration
• mGlu3 Antagonists Assessment by Stage and Route of Administration
• mGlu3 Antagonists Assessment by Molecule Type
• mGlu3 Antagonists Assessment by Stage and Molecule Type
• mGlu3 Antagonists Therapeutics – Discontinued Products
• mGlu3 Antagonists Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for mGlu3 Antagonists by Therapy Area, 2014
• Number of Products under Development for mGlu3 Antagonists, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• mGlu3 Antagonists Assessment by Monotherapy Products
• mGlu3 Antagonists Assessment by Combination Products
• mGlu3 Antagonists Assessment by Route of Administration
• mGlu3 Antagonists Assessment by Stage and Route of Administration
• mGlu3 Antagonists Assessment by Molecule Type
• mGlu3 Antagonists Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 3D細胞培養の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they wou …
  • ジェットノズルウォッシャーの世界市場
    Jet Nozzle Washer Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germ …
  • 世界及び中国の塩化ニオブ市場2009-2019
    Market Research Report on Global and Chinese Niobium chloride Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Niobium chloride industry. The report firstly reviews the basic information of Niobium chloride including its classification, application and manufactu …
  • 世界及び中国のEDTMPA市場2017
    The 'Global and Chinese EDTMPA Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global EDTMPA industry with a focus on the Chinese market. The report provides key statistics on the market status of the EDTMPA manufacturers and is a valuable …
  • 建設機械・鉱山機械市場(~2018):フィンランド(市場規模、動向、予測)
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for construction and mining machinery in Finland. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource …
  • (株)コーエンスエナジー(COENS Energy Co.)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 超伝導体の世界主要国市場
    This report studies Superconductor in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa,focuses on the top Manufacturers in each country, covering Luvata Oxford Bruker …
  • エチオンアミドの世界市場2018
    The Global Ethionamide (CAS 536-33-4) Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Ethionamide industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain stru …
  • 世界主要国におけるD-マンノース市場2017-2022
    The Global D-Mannose market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies D-Mannose in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, Chin …
  • 円筒形ドアロックの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Cylindrical Door Lock Revenue, means the sales value of Cylindrical Door Lock This report studies sales (consumption) of Cylindrical Door Lock in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countr …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014453 )"mGlu3 Antagonists:アンタゴニストのグローバル市場2014(薬開発、治験動向)" (英文:mGlu3 Antagonists -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。